血糖モニタリングシステムの世界市場：洞察、競合情勢、市場予測：2030年

血糖モニタリングシステム市場は、2024年に121億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に7.72%のCAGRで拡大し、2030年には188億9,000万米ドルに達すると予測されています。

血糖モニタリングシステム市場は、糖尿病や耐糖能異常などの生活習慣病の有病率の上昇、主要企業による製品の上市や承認の増加、低侵襲技術への嗜好の高まりなどにより急速に拡大しており、2024年から2030年にかけて血糖モニタリングシステムの需要を大きく牽引すると予測されます。

国際糖尿病連合（International Diabetes Federation）のデータ（2022年）によると、2021年には20～79歳の成人が5億3,700万人、約10人に1人が糖尿病を患っていました。この数は2030年には6億4,300万人に増加し、2045年には7億8,300万人に達すると予想されています。注目すべきは、成人の糖尿病患者の75％以上が低・中所得国に居住していることです。さらに、5億4,100万人の成人が耐糖能障害を有しており、2型糖尿病の発症リスクが高くなっています。

血糖モニタリングシステムは、特に糖尿病有病率の高い中低所得国において、糖尿病を管理し、その進行を予防するために不可欠なツールです。これらのシステムにより、個人は定期的に血糖値をチェックし管理することができ、食事、運動、薬物療法をタイムリーに調整することができます。耐糖能異常のある人は、モニタリングによって早期のグルコース変動を特定し、2型糖尿病の発症を予防するための介入を支援することができます。これらのシステムの効果的な使用は、より良い疾病管理、合併症の減少、全体的な健康転帰の改善につながります。

当レポートでは、世界の血糖モニタリングシステム市場について調査し、市場の概要とともに、製品タイプ別、モダリティ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 血糖モニタリングシステム市場レポートのイントロダクション

第2章 血糖モニタリングシステム市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 血糖モニタリングシステム市場の主な要因分析

• 血糖モニタリングシステムの市場促進要因
• 血糖モニタリングシステムの市場抑制要因と課題
• 血糖モニタリングシステムの市場機会

第6章 血糖モニタリングシステム市場ポーターのファイブフォース分析

第7章 血糖モニタリングシステム市場の評価

• 製品タイプ別
• モダリティ別
• エンドユーザー別
• 地域別

第8章 血糖モニタリングシステム市場の企業と製品プロファイル

• Medtronic
• Abbott
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services, Inc.
• Dexcom Inc.
• ARKRAY, Inc.
• Senseonics
• WaveForm Technologies, Inc.
• B. Braun Melsungen AG
• Ascensia Diabetes Care Holdings AG.
• Ypsomed
• i-SENS, Inc.
• Intuity Medical, Inc.
• ACON Laboratories, Inc.
• Prodigy Diabetes Care, LLC
• Sinocare
• Rossmax International Ltd.
• Menarini Diagnostics s.r.l.
• Bionime Corporation.
• Nemaura.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Blood Glucose Monitoring Systems Market in Global (2021-2030)
• Table 3: Blood Glucose Monitoring Systems Market in Global by Product Type (2021-2030)
• Table 4: Blood Glucose Monitoring Systems Market in Global by Modality (2021-2030)
• Table 5: Blood Glucose Monitoring Systems Market in Global by End-User (2021-2030)
• Table 6: Blood Glucose Monitoring Systems Market in Global by Geography (2021-2030)
• Table 7: Blood Glucose Monitoring Systems Market in North America (2021-2030)
• Table 8: Blood Glucose Monitoring Systems Market in the United States (2021-2030)
• Table 9: Blood Glucose Monitoring Systems Market in Canada (2021-2030)
• Table 10: Blood Glucose Monitoring Systems Market in Mexico (2021-2030)
• Table 11: Blood Glucose Monitoring Systems Market in Europe (2021-2030)
• Table 12: Blood Glucose Monitoring Systems Market in France (2021-2030)
• Table 13: Blood Glucose Monitoring Systems Market in Germany (2021-2030)
• Table 14: Blood Glucose Monitoring Systems Market in United Kingdom (2021-2030)
• Table 15: Blood Glucose Monitoring Systems Market in Italy (2021-2030)
• Table 16: Blood Glucose Monitoring Systems Market in Spain (2021-2030)
• Table 17: Blood Glucose Monitoring Systems Market in the Rest of Europe (2021-2030)
• Table 18: Blood Glucose Monitoring Systems Market in Asia-Pacific (2021-2030)
• Table 19: Blood Glucose Monitoring Systems Market in China (2021-2030)
• Table 20: Blood Glucose Monitoring Systems Market in Japan (2021-2030)
• Table 21: Blood Glucose Monitoring Systems Market in India (2021-2030)
• Table 22: Blood Glucose Monitoring Systems Market in Australia (2021-2030)
• Table 23: Blood Glucose Monitoring Systems Market in South Korea (2021-2030)
• Table 24: Blood Glucose Monitoring Systems Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Blood Glucose Monitoring Systems Market in the Rest of the World (2021-2030)
• Table 26: Blood Glucose Monitoring Systems Market in the Middle East (2021-2030)
• Table 27: Blood Glucose Monitoring Systems Market in Africa (2021-2030)
• Table 28: Blood Glucose Monitoring Systems Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Blood Glucose Monitoring Systems Market in Global (2021-2030)
• Figure 3: Blood Glucose Monitoring Systems Market in Global by Product Type (2021-2030)
• Figure 4: Blood Glucose Monitoring Systems Market in Global by Modality (2021-2030)
• Figure 5: Blood Glucose Monitoring Systems Market in Global by End-User (2021-2030)
• Figure 6: Blood Glucose Monitoring Systems Market in Global by Geography (2021-2030)
• Figure 7: Blood Glucose Monitoring Systems Market in North America (2021-2030)
• Figure 8: Blood Glucose Monitoring Systems Market in the United States (2021-2030)
• Figure 9: Blood Glucose Monitoring Systems Market in Canada (2021-2030)
• Figure 10: Blood Glucose Monitoring Systems Market in Mexico (2021-2030)
• Figure 11: Blood Glucose Monitoring Systems Market in Europe (2021-2030)
• Figure 12: Blood Glucose Monitoring Systems Market in France (2021-2030)
• Figure 13: Blood Glucose Monitoring Systems Market in Germany (2021-2030)
• Figure 14: Blood Glucose Monitoring Systems Market in United Kingdom (2021-2030)
• Figure 15: Blood Glucose Monitoring Systems Market in Italy (2021-2030)
• Figure 16: Blood Glucose Monitoring Systems Market in Spain (2021-2030)
• Figure 17: Blood Glucose Monitoring Systems Market in the Rest of Europe (2021-2030)
• Figure 18: Blood Glucose Monitoring Systems Market in Asia-Pacific (2021-2030)
• Figure 19: Blood Glucose Monitoring Systems Market in China (2021-2030)
• Figure 20: Blood Glucose Monitoring Systems Market in Japan (2021-2030)
• Figure 21: Blood Glucose Monitoring Systems Market in India (2021-2030)
• Figure 22: Blood Glucose Monitoring Systems Market in Australia (2021-2030)
• Figure 23: Blood Glucose Monitoring Systems Market in South Korea (2021-2030)
• Figure 24: Blood Glucose Monitoring Systems Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Blood Glucose Monitoring Systems Market in the Rest of the World (2021-2030)
• Figure 26: Blood Glucose Monitoring Systems Market in the Middle East (2021-2030)
• Figure 27: Blood Glucose Monitoring Systems Market in Africa (2021-2030)
• Figure 28: Blood Glucose Monitoring Systems Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Blood Glucose Monitoring Systems Market by Product Type (Self-Monitoring Blood Glucose Systems and Continuous Glucose Monitoring Systems), Modality (Wearable and Non-Wearable), End-User (Hospitals, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of lifestyle style disorders and increasing product developmental activities worldwide

The blood glucose monitoring systems market was valued at USD 12.12 billion in 2024, growing at a CAGR of 7.72% during the forecast period from 2024 to 2030 to reach USD 18.89 billion by 2030. The blood glucose monitoring systems market is expanding rapidly due to the rising prevalence of lifestyle style disorders such as diabetes and impaired glucose tolerance, growing product launches and approvals by key players, and a rising preference for minimally invasive techniques that are expected to significantly drive the demand for blood glucose monitoring systems from 2024 to 2030.

Blood Glucose Monitoring Systems Market Dynamics:

According to data from the International Diabetes Federation (2022), in 2021, 537 million adults aged 20-79 were living with diabetes, equating to about 1 in 10 individuals. This number is expected to increase to 643 million by 2030 and reach 783 million by 2045. Notably, over 75% of adults with diabetes reside in low- and middle-income countries. Additionally, 541 million adults have impaired glucose tolerance, putting them at elevated risk for developing type 2 diabetes.

Blood glucose monitoring systems are essential tools for managing diabetes and preventing its progression, particularly in low- and middle-income countries where the prevalence is high. These systems enable individuals to regularly check and manage their blood glucose levels, allowing for timely adjustments in diet, exercise, and medication. For those with impaired glucose tolerance, monitoring can help identify early glucose fluctuations and support interventions to prevent the onset of type 2 diabetes. Effective use of these systems can lead to better disease management, reducing complications and improving overall health outcomes.

Moreover, companies are amplifying their production of blood glucose monitoring systems and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in January 2024, Medtronic, a global leader in healthcare technology, announced CE Mark approval for the MiniMed(TM) 780G system with Simplera Sync(TM), a disposable, all-in-one continuous glucose monitor that required no fingersticks or overtape. Simplera Sync(TM) featured an improved user experience with a simple, two-step insertion process.

Therefore, all the factors stated above collectively will drive the overall blood glucose monitoring systems market during the forecast period from 2024 to 2030.

However, false readings or technical errors can lead to incorrect insulin dosing which is associated with hypoglycaemia or hyperglycaemia, availability of alternative options among others may limit their end-user base, thus acting as key constraints limiting the growth of the blood glucose monitoring systems market.

Blood Glucose Monitoring Systems Market Segment Analysis:

Blood Glucose Monitoring Systems Market by Product Type (Self-Monitoring Blood Glucose Systems and Continuous Glucose Monitoring Systems), Modality (Wearable and Non-Wearable), End-User (Hospitals, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of blood glucose monitoring systems, the continuous glucose monitoring systems category is expected to have a significant revenue share in the year 2023. This is due to the key features and widespread application provided by these.

Continuous glucose monitoring systems provide real-time tracking of blood glucose levels by using a small sensor placed under the skin to measure glucose in interstitial fluid. These offer continuous monitoring and can update readings every few minutes, reducing the need for frequent manual checks. Key features include alarms for high or low glucose levels, calibration-free technology, and integration with smartphones and digital health platforms for detailed data analysis and trend visualization.

These systems are especially beneficial for individuals with Type 1 and Type 2 diabetes, helping them achieve better glycemic control, reduce the risk of hypoglycemia, and optimize insulin therapy through integration with insulin pumps or artificial pancreas systems. Additionally, they are widely used in clinical research to analyze glucose patterns and develop new treatment strategies, making them indispensable for personalized diabetes management and improving patient outcomes.

Rising product developmental activities by regulatory bodies will further boost the market for the same. For example, in June 2024, Abbott announced that the US Food and Drug Administration (FDA) approved two new over-the-counter continuous glucose monitoring systems - Lingo(TM) and Libre Rio(TM). These systems were based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology.

Therefore, owing to the above-mentioned factors, the demand for the continuous glucose monitoring category upsurges, owing to which the category is expected to witness considerable growth eventually contributing to the overall growth of the blood glucose monitoring systems market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall blood glucose monitoring systems market:

Among all the regions, North America is expected to dominate the blood glucose monitoring systems market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is driven by the rising cases of diabetes, advancement in blood glucose monitoring systems, regulatory support, and introduction of innovative products by the key market players that are anticipated to significantly propel market growth for blood glucose monitoring systems from 2024 to 2030.

As per the recent data provided by the Centre for Disease Control and Prevention (2024), in 2021, 38.4 million people of all ages, or 11.6% of the US population had diabetes. Blood glucose monitoring systems are essential tools for managing diabetes, helping individuals regularly check and maintain their blood sugar levels. These systems, including finger-stick glucometers and continuous glucose monitors, enable users to track glucose fluctuations throughout the day. This information allows for timely adjustments in diet, physical activity, and medication to maintain optimal blood sugar levels, prevent complications, and manage diabetes effectively.

Additionally, the increasing number of product development activities in the region by the regulatory bodies is further going to accelerate the growth of the blood glucose monitoring systems market. For instance, in August 2024, Medtronic plc, a global leader in healthcare technology, announced the U.S. Food and Drug Administration (FDA) approved its Simplera(TM) continuous glucose monitor (CGM). This approval marked the launch of the company's first disposable, all-in-one CGM, which was half the size of previous Medtronic CGMs.

In addition to this in June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, announced the launch of its first remote blood glucose monitoring device, the Pylo GL1-LTE. The blood glucose meter was clinically validated and connected to multiple cellular networks to ensure reliable data transmission throughout the US.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the blood glucose monitoring systems market.

Blood Glucose Monitoring Systems Market key players:

Some of the key market players operating in the blood glucose monitoring systems market include Medtronic, Abbott, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., Menarini Diagnostics s.r.l., Bionime Corporation., Nemaura., and others.

Recent Developmental Activities in the Blood Glucose Monitoring Systems Market:

• In May 2024, Smart Meter launched iGlucose Plus for diabetes management, a cellular-enabled glucose meter that eliminated the need for syncing, pairing, or relying on smartphones and Wi-Fi.
• In February 2024, Dexcom launched its real-time continuous glucose monitoring solution, Dexcom ONE+, in Europe. Dexcom ONE+ was a customizable CGM solution designed to be worn at three different locations on the body.
• In November 2021, Intuity Medical launched the POGO Automatic Blood Glucose Monitoring System for diabetes patients in the US.
• In July 27, 2021, Terumo launched the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Japan, which is manufactured by Dexcom, Inc.

Key Takeaways from the Blood Glucose Monitoring Systems Market Report Study

• Market size analysis for current blood glucose monitoring systems market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the blood glucose monitoring systems market
• Various opportunities available for the other competitors in the blood glucose monitoring systems market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current blood glucose monitoring systems market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for blood glucose monitoring systems market growth in the coming future?

Target audience who can be benefited from this Blood Glucose Monitoring Systems Market Report Study

• Blood glucose monitoring systems product providers
• Research organizations and consulting companies
• Blood glucose monitoring systems-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in blood glucose monitoring systems
• Various end-users who want to know more about the blood glucose monitoring systems market and the latest developments in the blood glucose monitoring systems market

Frequently Asked Questions for the Blood Glucose Monitoring Systems Market:

1. What are Blood Glucose Monitoring Systems?

The blood glucose monitoring systems are used at home or in health care settings to measure/monitor the amount glucose level in the blood. There are two types of blood glucose monitors available in the market - self-monitoring blood glucose monitoring systems and continuous glucose monitoring systems.

2. What is the market for Blood Glucose Monitoring Systems?

The blood glucose monitoring systems market was valued at USD 12.12 billion in 2024, growing at a CAGR of 7.72% during the forecast period from 2024 to 2030 to reach USD 18.89 billion by 2030.

3. What are the drivers for the Blood Glucose Monitoring Systems market?

The blood glucose monitoring systems market is expanding rapidly due to the rising prevalence of lifestyle style disorders such as diabetes and impaired glucose tolerance, growing product launches and approvals by key players, and a rising preference for minimally invasive techniques that are expected to significantly drive the demand for blood glucose monitoring systems from 2024 to 2030.

4. Who are the key players operating in the Blood Glucose Monitoring Systems market?

Some of the key market players operating in the blood glucose monitoring systems market are Medtronic, Abbott, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., Menarini Diagnostics s.r.l., Bionime Corporation., Nemaura., and others.

5. Which region has the highest share in the Blood Glucose Monitoring Systems market?

Among all the regions, North America is estimated to hold a significant revenue share in the blood glucose monitoring systems market. This is driven by the rising cases of diabetes, advancement in blood glucose monitoring systems, regulatory support, and introduction of innovative products by the key market players that are anticipated to significantly propel market growth for blood glucose monitoring systems from 2024 to 2030.

Table of Contents

1. Blood Glucose Monitoring Systems Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Blood Glucose Monitoring Systems Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Blood Glucose Monitoring Systems Market Key Factors Analysis

• 5.1. Blood Glucose Monitoring Systems Market Drivers
  • 5.1.1. Increasing instances of lifestyle disorders
  • 5.1.2. Increase in product developmental activities
  • 5.1.3. Growing preference for minimally invasive technique
• 5.2. Blood Glucose Monitoring Systems Market Restraints and Challenges
  • 5.2.1. False readings or technical errors can lead to incorrect insulin dosing, associated with hypoglycemia or hyperglycemia
  • 5.2.2. Availability of alternative options
• 5.3. Blood Glucose Monitoring Systems Market Opportunities
  • 5.3.1. Increasing adoption of digital health solutions
  • 5.3.2. Integration capabilities with smartphones, wearables, and other IoT devices

6. Blood Glucose Monitoring Systems Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Blood Glucose Monitoring Systems Market Assessment

• 7.1. By Product Type
  • 7.1.1. Self-Monitoring Blood Glucose Systems
  • 7.1.2. Continuous Glucose Monitoring Systems
• 7.2. By Modality
  • 7.2.1. Wearable
  • 7.2.2. Non-wearable
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Home care settings
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.3.3. India Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Blood Glucose Monitoring Systems Market Size in USD million (2021-2030)

8. Blood Glucose Monitoring Systems Market Company and Product Profiles

• 8.1. Medtronic
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Abbott
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. F. Hoffmann-La Roche Ltd.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Johnson & Johnson Services, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Dexcom Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. ARKRAY, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Senseonics
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. WaveForm Technologies, Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. B. Braun Melsungen AG
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Ascensia Diabetes Care Holdings AG.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Ypsomed
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. i-SENS, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Intuity Medical, Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. ACON Laboratories, Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Prodigy Diabetes Care, LLC
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Sinocare
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Rossmax International Ltd.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Menarini Diagnostics s.r.l.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Bionime Corporation.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Nemaura.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us